Literature DB >> 35273720

Bariatric surgery for the management of type 2 diabetes mellitus-current trends and challenges: a review article.

Mansur Suliman Alqunai1,2, Fauwaz Fahad Alrashid3.   

Abstract

Obesity has become an epidemic and has emerged as a serious ailment of global concern. Longstanding obesity may lead to several complications, including type 2 diabetes mellitus (T2DM). Considering the role of the gastrointestinal tract (GIT) in glycemic control, altering it would be relevant to the T2DM management algorithm. Bariatric surgery is a well-known surgical procedure that alters the GIT for managing T2DM among moderate to severely obese patients. T2DM remissions (adequate glycemic control without any other antidiabetic drugs) among the post-bariatric patients are due to weight loss related and weight loss unrelated pathophysiological mechanisms, including caloric intake restriction, increased insulin secretion, sensitivity, and malabsorption. Evidence suggests that bariatric surgeries among T2DM patients improved micro and macrovascular complications. Bariatric surgical procedures have more advantages of post-operative weight loss and glycemic control in biliopancreatic diversions than other available bariatric surgical procedures. Several concerns raised on the short and long-term risks associated with the bariatric surgery were nutritional deficiencies, psychological issues, GIT ulcers, and survival rates. Data related to follow-up of complications related to the above-stated risk are still elusive. According to some of the recently published studies, relapse of T2DM after remission is a worrying phenomenon among post-bariatric surgery patients, requiring more clinical trials and long-term follow-up on the relapsed patients. The effectiveness of reoperation among the relapsed patients also needs to be evaluated. Other unresolved issues related to bariatric surgery are patient compliance, cost-effectiveness, quality of life among post-bariatric patients, and the effectiveness of the post-operative holistic approach to avoid relapse. Future studies, especially randomized controlled trials, are recommended to resolve the existing controversies associated with bariatric surgery. AJTR
Copyright © 2022.

Entities:  

Keywords:  Bariatric surgery; nutritional deficiency; remission; type 2 diabetes mellitus

Year:  2022        PMID: 35273720      PMCID: PMC8902546     

Source DB:  PubMed          Journal:  Am J Transl Res        ISSN: 1943-8141            Impact factor:   4.060


  67 in total

1.  Determinants of Diabetes Remission and Glycemic Control After Bariatric Surgery.

Authors:  Simona Panunzi; Lena Carlsson; Andrea De Gaetano; Markku Peltonen; Toni Rice; Lars Sjöström; Geltrude Mingrone; John B Dixon
Journal:  Diabetes Care       Date:  2015-12-01       Impact factor: 19.112

Review 2.  The long-term effects of bariatric surgery for type 2 diabetes: systematic review and meta-analysis of randomized and non-randomized evidence.

Authors:  Jiajie Yu; Xu Zhou; Ling Li; Sheyu Li; Jing Tan; Youping Li; Xin Sun
Journal:  Obes Surg       Date:  2015-01       Impact factor: 4.129

3.  Prediction of Diabetes Remission in Morbidly Obese Patients After Roux-en-Y Gastric Bypass.

Authors:  Ji Yeon Park; Yong Jin Kim
Journal:  Obes Surg       Date:  2016-04       Impact factor: 4.129

Review 4.  Bone Health After Bariatric Surgery.

Authors:  Claudia Gagnon; Anne L Schafer
Journal:  JBMR Plus       Date:  2018-05-01

5.  Bariatric-metabolic surgery versus conventional medical treatment in obese patients with type 2 diabetes: 5 year follow-up of an open-label, single-centre, randomised controlled trial.

Authors:  Geltrude Mingrone; Simona Panunzi; Andrea De Gaetano; Caterina Guidone; Amerigo Iaconelli; Giuseppe Nanni; Marco Castagneto; Stefan Bornstein; Francesco Rubino
Journal:  Lancet       Date:  2015-09-05       Impact factor: 79.321

Review 6.  Adipose Tissue-Resident Immune Cells in Obesity and Type 2 Diabetes.

Authors:  Jingli Lu; Junjie Zhao; Haiyang Meng; Xiaojian Zhang
Journal:  Front Immunol       Date:  2019-05-22       Impact factor: 7.561

Review 7.  Preventing Wernicke Encephalopathy After Bariatric Surgery.

Authors:  Erik Oudman; Jan W Wijnia; Mirjam van Dam; Laser Ulas Biter; Albert Postma
Journal:  Obes Surg       Date:  2018-07       Impact factor: 4.129

8.  The Prevalence and Risk Factors of Type 2 Diabetes Mellitus (DMT2) in a Semi-Urban Saudi Population.

Authors:  Mohammed Abdullah Al Mansour
Journal:  Int J Environ Res Public Health       Date:  2019-12-18       Impact factor: 3.390

View more
  1 in total

1.  Comprehensive Network Analysis Reveals the Targets and Potential Multitarget Drugs of Type 2 Diabetes Mellitus.

Authors:  Wan Zhou; Qiang Liu; Wei Wang; Xiao-Jing Yuan; Chun-Chun Xiao; Shan-Dong Ye
Journal:  Oxid Med Cell Longev       Date:  2022-07-28       Impact factor: 7.310

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.